Literature DB >> 12149340

Differentiation of foot-and-mouth disease virus-infected from vaccinated pigs by enzyme-linked immunosorbent assay using nonstructural protein 3AB as the antigen and application to an eradication program.

Wen-Bin Chung1, Karl Johan Sorensen, Pei-Chih Liao, Pin-Cheng Yang, Ming-Hwa Jong.   

Abstract

Baculovirus-expressed foot-and-mouth disease virus (FMDV) nonstructural protein 3AB was used as the antigen in an enzyme-linked immunosorbent assay. This assay allowed the differentiation of vaccinated from infected pigs. Serial studies were performed using sera collected from pigs in the field. Positive reactions were found in sera from fattening pigs and sows 16 weeks and 3.5 years postoutbreak, respectively. There was, however, no positive reaction in sows with at least 10 vaccinations. Maternally derived antibodies to the 3AB antigen persisted in piglets up to 13 weeks of age. A high correlation coefficient (r = 0.93) was found between the test results from sow sera and those from their offspring. Therefore, piglet serum was a good substitute for sow serum to monitor the infection status of the dam. The application of this assay to serological surveillance in an FMD eradication program in Taiwan showed that the positive reactors steadily decreased over time in both finishers and sows, indicating that the pig population risk of infection by FMDV has decreased.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12149340      PMCID: PMC120658          DOI: 10.1128/JCM.40.8.2843-2848.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Differentiation of convalescent animals from those vaccinated against foot-and-mouth disease by a peptide ELISA.

Authors:  F Shen; P D Chen; A M Walfield; J Ye; J House; F Brown; C Y Wang
Journal:  Vaccine       Date:  1999-08-06       Impact factor: 3.641

2.  Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay.

Authors:  I E Bergmann; V Malirat; E Neitzert; E Beck; N Panizzutti; C Sánchez; A Falczuk
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

3.  Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals.

Authors:  R F Meyer; G D Babcock; J F Newman; T G Burrage; K Toohey; J Lubroth; F Brown
Journal:  J Virol Methods       Date:  1997-04       Impact factor: 2.014

4.  Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus.

Authors:  C W Beard; P W Mason
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Foot-and-mouth disease virus-infected but not vaccinated cattle develop antibodies against recombinant 3AB1 nonstructural protein.

Authors:  E Silberstein; G Kaplan; O Taboga; S Duffy; E Palma
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

6.  Differentiation of infection from vaccination in foot-and-mouth disease by the detection of antibodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus.

Authors:  K J Sørensen; K G Madsen; E S Madsen; J S Salt; J Nqindi; D K Mackay
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

7.  Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan.

Authors:  P C Yang; R M Chu; W B Chung; H T Sung
Journal:  Vet Rec       Date:  1999 Dec 18-25       Impact factor: 2.695

8.  The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle.

Authors:  M De Diego; E Brocchi; D Mackay; F De Simone
Journal:  Arch Virol       Date:  1997       Impact factor: 2.574

9.  Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA.

Authors:  D K Mackay; M A Forsyth; P R Davies; A Berlinzani; G J Belsham; M Flint; M D Ryan
Journal:  Vaccine       Date:  1998-03       Impact factor: 3.641

10.  Identification of foot-and-mouth disease virus replication in vaccinated cattle by antibodies to non-structural virus proteins.

Authors:  H G Berger; O C Straub; R Ahl; M Tesar; O Marquardt
Journal:  Vaccine       Date:  1990-06       Impact factor: 3.641

View more
  5 in total

1.  Comparison of two 3ABC enzyme-linked immunosorbent assays for diagnosis of multiple-serotype foot-and-mouth disease in a cattle population in an area of endemicity.

Authors:  B M de C Bronsvoort; K J Sørensen; J Anderson; A Corteyn; V N Tanya; R P Kitching; K L Morgan
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals.

Authors:  Sabena Uddowla; Jason Hollister; Juan M Pacheco; Luis L Rodriguez; Elizabeth Rieder
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

3.  Evaluation of three 3ABC ELISAs for foot-and-mouth disease non-structural antibodies using latent class analysis.

Authors:  Barend M deC Bronsvoort; Nils Toft; Ingrid E Bergmann; Karl-Johan Sørensen; John Anderson; Viviane Malirat; Vincent N Tanya; Kenton L Morgan
Journal:  BMC Vet Res       Date:  2006-10-16       Impact factor: 2.741

4.  Development and Validation of a Mucosal Antibody (IgA) Test to Identify Persistent Infection with Foot-and-Mouth Disease Virus.

Authors:  Jitendra K Biswal; Antonello Di Nardo; Geraldine Taylor; David J Paton; Satya Parida
Journal:  Viruses       Date:  2021-05-01       Impact factor: 5.048

5.  Development of a competitive chemiluminescence immunoassay using a monoclonal antibody recognizing 3B of foot-and-mouth disease virus for the rapid detection of antibodies induced by FMDV infection.

Authors:  Wei Liu; Guanglei Zhang; Sicheng Yang; Junhui Li; Zhan Gao; Sudan Ge; Huihui Yang; Junjun Shao; Huiyun Chang
Journal:  Virol J       Date:  2021-09-26       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.